🇺🇸 FDA
Patent

US 8993552

Compositions and methods for treatment of leukemia

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 8993552 (Compositions and methods for treatment of leukemia) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/519, A61K31/5377, A61K31/551, A61K31/5513